Jan 26, 2023 04:05PM
Oct 26, 2022 08:30AM
Oct 24, 2022 04:30PM
Oct 24, 2022 04:30PM
Oct 24, 2022 05:54AM
Oct 23, 2022 11:36PM
Oct 23, 2022 11:36PM Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
Oct 23, 2022 11:30PM
Oct 14, 2022 10:02AM
Oct 14, 2022 06:45AM
Oct 3, 2022 08:15AM
Oct 3, 2022 05:52AM
Oct 2, 2022 07:36PM
Oct 2, 2022 07:36PM Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares
Aug 5, 2022 08:50PM
Aug 5, 2022 08:50PM
Jul 27, 2022 04:05PM
Jul 27, 2022 04:05PM
Jul 13, 2022 06:45AM
Jun 17, 2022 06:46AM
Jun 17, 2022 06:45AM Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain
Jun 17, 2022 06:45AM
Jun 2, 2022 06:51AM
Jun 2, 2022 06:50AM
Jun 2, 2022 06:50AM
May 10, 2022 08:00AM
May 10, 2022 08:00AM
May 10, 2022 06:55AM Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fiscal Year Ended March 31, 2022
May 10, 2022 06:55AM
May 6, 2022 06:45AM
May 6, 2022 06:45AM
May 6, 2022 06:45AM
Apr 26, 2022 08:30AM
Apr 12, 2022 05:43AM
Apr 12, 2022 12:00AM Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated with Endometriosis
Apr 12, 2022 12:00AM
Jan 26, 2022 06:55AM
Jan 26, 2022 06:55AM
Jan 12, 2022 08:30AM
Jan 12, 2022 08:30AM
Jan 10, 2022 06:56AM
Jan 10, 2022 06:55AM Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021
Oct 26, 2021 06:55AM
Oct 19, 2021 06:58AM
Oct 19, 2021 06:58AM
Oct 19, 2021 06:58AM
Oct 12, 2021 08:30AM
Oct 12, 2021 08:30AM
Sep 9, 2021 06:59AM Myovant Sciences (MYOV), Pfizer (PFE) Announce FDA Acceptance of sNDA for MYFEMBREE for Management of Moderate to Severe Pain Associated With Endometriosis
Sep 9, 2021 06:58AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All